Isotretinoin: Side Effects, Uses, Dosage, Interactions, Warnings In February 2002, Roche's patents for isotretinoin expired, allowing generic drugs to enter the market. In 2001, the FDA announced the System to Manage Accutane Related Teratogenicity (SMAR : Notes
You are about to be redirected to another page. We are not responsible for the content of that page or the consequences it may have on you.